Berkcan Akpinar
Sports Medicine · New York, NYNPI 1659869154
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (49.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 41.3% of the total. Reporting peaked in 2023 at $26,639 and has fallen 88.0% since, to $3,207 in 2025. Among sports medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $442.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$22K
- Smith+Nephew$15K
- Stryker$8K
- Vericel Corporation$6K
- Medical Device Business Services, Inc.$594
- Exactech, Inc.$589
- plus $1K from 11 others
What the payments were for
- Consulting fees$5,50010%
- Grants$25,83349%
- Travel & lodging$10,16919%
- Food & beverage$5,33010%
- Education$5,83311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 25 | $21,763 |
| Smith+Nephew | 25 | $15,050 |
| Stryker | 42 | $8,033 |
| Vericel Corporation | 5 | $5,632 |
| Medical Device Business Services, Inc. | 5 | $594 |
| Exactech, Inc. | 2 | $589 |
| Johnson & Johnson | 3 | $287 |
| Davol Inc. | 2 | $263 |
| Miach Orthopaedics, Inc. | 1 | $161 |
| Bone Support Inc. | 1 | $90 |
| Southern Edge Orthopaedics, Inc. | 1 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Kairos Surgical Inc | 1 | $30 |
| Biotronik NRO, Inc. | 1 | $25 |
| AbbVie | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$5,500
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$1,978
- ICONIX$1,945
- MAKO$1,307
- PANGEA$1,155
- Bone Anchors with Arthroscopic Delivery System$1,109
- Q-FIX$776
- EQUINOXE$563
- HEALIX KNOTLESS PEEK$529
- PROCINCH$465
- GAMMA$343
- T2 ALPHA$294
- TRUESPAN ORTHOCORD$256
- Journey II$255
- 1788$225
- ALPHAVENT$174
- TRIGEN InterTAN$147
- R3 ACETABULAR$128
- Tandem$128
- POLARSTEM$128
How this compares
$52,666 in reported general payments places this provider in the 90th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 67 | $198 |
| Oxycodone Hcl | 14 | $67 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in New York
- Gregory DifeliceNew York$1.8M
- Theodore BlaineNew York$765K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$592K
- Riley WilliamsNew York$512K
- Bryan KellyNew York$409K
- Samuel TaylorNew York$255K
- Eric StraussNew York$241K
- Michael FuNew York$210K
- Michael AlaiaNew York$207K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.